Seeing Is Believing
Currently out of the existing stock ratings of Laura Chico, 213 are a BUY (67.19%), 101 are a HOLD (31.86%), 3 are a SELL (0.95%).
Analyst Laura Chico, currently employed at WEDBUSH, carries an average stock price target met ratio of 48.11% that have a potential upside of 35.82% achieved within 178 days.
Laura Chico’s has documented 642 price targets and ratings displayed on 40 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VIGL, Vigil Neuroscience at 22-May-2025.
Analyst best performing recommendations are on LBPH (LONGBOARD PHARMACEUTICALS).
The best stock recommendation documented was for DNLI (DENALI THERAPEUTICS) at 11/10/2020. The price target of $64 was fulfilled within 1 day with a profit of $4 (6.67%) receiving and performance score of 66.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$1.5
$0.84 (127.27%)
$10
1 years 9 months 2 days ago
(01-Sep-2023)
0/3 (0%)
$0.36 (31.58%)
Buy
$8
$7.34 (1112.12%)
$9
3 years 2 months 27 days ago
(07-Mar-2022)
0/2 (0%)
$5.54 (225.20%)
Buy
$8
$7.34 (1112.12%)
$48
5 years 11 months 9 days ago
(25-Jun-2019)
0/4 (0%)
$3.88 (94.17%)
Which stock is Laura Chico is most bullish on?
Which stock is Laura Chico is most reserved on?
What Year was the first public recommendation made by Laura Chico?